A novel tp53-associated nomogram to predict the overall survival in patients with pancreatic cancer
Abstract Background Gene mutations play critical roles in tumorigenesis and cancer development. Our study aimed to screen survival-related mutations and explore a novel gene signature to predict the overall survival in pancreatic cancer. Methods Somatic mutation data from three cohorts were used to...
Main Authors: | Xun Liu, Bobo Chen, Jiahui Chen, Shaolong Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08066-2 |
Similar Items
-
TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
by: Yiran Zhou, et al.
Published: (2023-12-01) -
TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer
by: Feng Zhang, et al.
Published: (2021-05-01) -
Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: a SEER-based nomogram analysis
by: Jian Li, et al.
Published: (2019-07-01) -
Tp53 Mutation Inhibits Ubiquitination and Degradation of WISP1 via Down-Regulation of Siah1 in Pancreatic Carcinogenesis
by: Wei Wu, et al.
Published: (2018-08-01) -
Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)